NO20012554D0 - Imidazo[4,5-b]pyridiniummetyl-inneholdende cefemforbindelser med bredt antibakterielt spektrum - Google Patents

Imidazo[4,5-b]pyridiniummetyl-inneholdende cefemforbindelser med bredt antibakterielt spektrum

Info

Publication number
NO20012554D0
NO20012554D0 NO20012554A NO20012554A NO20012554D0 NO 20012554 D0 NO20012554 D0 NO 20012554D0 NO 20012554 A NO20012554 A NO 20012554A NO 20012554 A NO20012554 A NO 20012554A NO 20012554 D0 NO20012554 D0 NO 20012554D0
Authority
NO
Norway
Prior art keywords
hydrogen
antibacterial spectrum
imidazo
optionally substituted
cephem compounds
Prior art date
Application number
NO20012554A
Other languages
English (en)
Other versions
NO20012554L (no
Inventor
Yasuhiro Nishitani
Hikaru Itani
Tadashi Irie
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20012554D0 publication Critical patent/NO20012554D0/no
Publication of NO20012554L publication Critical patent/NO20012554L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
NO20012554A 1998-11-27 2001-05-23 Imidazo[4,5-b]pyridiniummetyl-inneholdende cefemforbindelser med bredt antibakterielt spektrum NO20012554L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33670798 1998-11-27
PCT/JP1999/006562 WO2000032606A1 (fr) 1998-11-27 1999-11-25 COMPOSÉS DE CÉPHÈME À BASE D'IMIDAZO[4,5-b]PYRIDINIUMMÉTHYLE À LARGE SPECTRE ANTIBACTÉRIEN

Publications (2)

Publication Number Publication Date
NO20012554D0 true NO20012554D0 (no) 2001-05-23
NO20012554L NO20012554L (no) 2001-07-27

Family

ID=18301969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012554A NO20012554L (no) 1998-11-27 2001-05-23 Imidazo[4,5-b]pyridiniummetyl-inneholdende cefemforbindelser med bredt antibakterielt spektrum

Country Status (23)

Country Link
US (2) US6518263B1 (no)
EP (1) EP1134222B1 (no)
JP (1) JP3636663B2 (no)
KR (1) KR100692169B1 (no)
CN (1) CN100436456C (no)
AT (1) ATE293114T1 (no)
AU (1) AU758662B2 (no)
BR (1) BR9915743A (no)
CA (1) CA2350905C (no)
CZ (1) CZ20011719A3 (no)
DE (1) DE69924751T2 (no)
ES (1) ES2241374T3 (no)
HU (1) HUP0200450A3 (no)
ID (1) ID28740A (no)
IL (1) IL143314A0 (no)
NO (1) NO20012554L (no)
NZ (1) NZ511619A (no)
PL (1) PL347897A1 (no)
RU (1) RU2223964C2 (no)
TR (1) TR200101507T2 (no)
TW (1) TW526202B (no)
WO (1) WO2000032606A1 (no)
ZA (1) ZA200103850B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
IL148820A0 (en) * 1999-10-08 2002-09-12 Smithkline Beecham Corp Fab i inhibitors
JP2003012647A (ja) * 2000-10-04 2003-01-15 Shionogi & Co Ltd ２，３−ジアミノピリジンの製造方法
AU2002367773A1 (en) * 2001-04-06 2003-11-03 Affinium Pharmaceuticals, Inc. Fab i inhibitors
DE60205882D1 (de) * 2001-04-23 2005-10-06 Shionogi & Co Sulfat von cephemverbindung
WO2003068745A1 (fr) * 2002-02-14 2003-08-21 Shionogi & Co., Ltd. Procédé de production de dérivés de 2,3-diaminopyridine
DE60321548D1 (de) * 2002-03-13 2008-07-24 Janssen Pharmaceutica Nv Carbonylamino- derivativate als neue inhibitoren von histone deacetylase
AU2003241675A1 (en) * 2002-06-21 2004-01-06 Shionogi And Co., Ltd. Medicinal cephem compound composition for injection
JPWO2004026882A1 (ja) * 2002-09-20 2006-01-19 塩野義製薬株式会社 セフェム剤の製法
AU2003275682A1 (en) * 2002-10-29 2004-05-25 Shionogi And Co., Ltd. Crystal of inorganic acid salt of cephem compound
ATE368042T1 (de) 2002-10-30 2007-08-15 Astellas Pharma Inc Cephemverbindungen
AU2002952355A0 (en) * 2002-10-30 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US7790709B2 (en) 2002-12-06 2010-09-07 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
WO2005027909A1 (en) * 2003-09-18 2005-03-31 Astellas Pharma Inc. Cephem compounds
JP4535366B2 (ja) * 2003-12-03 2010-09-01 塩野義製薬株式会社 セフェム剤の製造方法
WO2005085258A1 (ja) * 2004-03-05 2005-09-15 Shionogi & Co., Ltd. ３−ピリジニウムメチルセフェム化合物
PT1828167E (pt) * 2004-06-04 2014-10-08 Debiopharm Int Sa Derivados de acrilamida como agentes antibióticos
JP2006206529A (ja) * 2005-01-31 2006-08-10 Shionogi & Co Ltd Ｎ−（４−ピリジル）エチレンジアミン誘導体
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
US8198434B2 (en) * 2008-05-07 2012-06-12 Idexx Laboratories, Inc. Process for preparing cefsulodin sodium
CN102443017B (zh) * 2010-10-13 2014-10-29 石药集团中奇制药技术（石家庄）有限公司 一种盐酸头孢唑兰的制备方法
EA028342B1 (ru) 2011-09-09 2017-11-30 Мерк Шарп И Доум Корп. Способы лечения пневмонии
RS58898B1 (sr) 2012-06-19 2019-08-30 Debiopharm Int Sa Prolek derivati (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamida
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
RS58700B1 (sr) 2012-10-12 2019-06-28 Broad Inst Inc Gsk3 inhibitori i postupci njihove primene
NZ700372A (en) 2013-03-15 2016-01-29 Merck Sharp & Dohme Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
EP3313821B1 (en) * 2015-06-29 2019-04-10 Sandoz AG Process for the preparation of carbamoylamino pyrazole derivatives
KR20180066264A (ko) * 2015-12-10 2018-06-18 나에자-알지엠 파마슈티칼스 유엘씨 세펨 화합물, 그의 제조 및 용도
LT3419628T (lt) 2016-02-26 2021-01-25 Debiopharm International Sa Medikamentas diabetinėms pėdų infekcijoms gydyti
WO2018187630A1 (en) 2017-04-05 2018-10-11 The Broad Institute, Inc. Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585199A (en) * 1967-05-25 1971-06-15 Merck & Co Inc (4-(3-(polyazaheterocyclic)alkanoyl)phenoxy)alkanoic acids
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
GR75644B (no) 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
DE3279470D1 (en) 1981-04-03 1989-04-06 Fujisawa Pharmaceutical Co New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
PL238158A1 (en) 1981-09-08 1984-11-19 Lilly Co Eli Method of obtaining new cephalosporin derivatives
US4406899A (en) 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
ZA838864B (en) * 1982-12-17 1984-11-28 Ici Pharma Process for the manufacture of cephalosporin derivatives
DE3248281A1 (de) 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
US4525473A (en) 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3409431A1 (de) 1983-10-08 1985-04-18 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3336757A1 (de) 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
ZA847926B (en) * 1983-10-17 1986-05-28 Lilly Co Eli 3-bicyclicpyridinium-methyl cephalosporins
US4692443A (en) * 1983-10-17 1987-09-08 Eli Lilly And Company 3-bicyclicpyridinium-methyl cephalosporins
JPS60120889A (ja) 1983-11-30 1985-06-28 Meiji Seika Kaisha Ltd 新規セファロスポリン化合物及びその製造法
US4547573A (en) 1983-12-02 1985-10-15 Ici Pharma Process for preparing cephalosporin derivatives
GB8401093D0 (en) 1984-01-16 1984-02-15 Fujisawa Pharmaceutical Co Cephem compounds
NO165842C (no) 1984-04-23 1991-04-17 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
IL77458A (en) 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
ATE89826T1 (de) 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
EP0203271B1 (en) 1985-03-01 1993-05-26 Takeda Chemical Industries, Ltd. Antibacterial compounds, their production and use
US4804658A (en) * 1986-09-15 1989-02-14 G. D. Searle & Co. Imidazopyridine derivatives and pharmaceutical compositions
GB8712747D0 (en) * 1987-05-30 1987-07-01 Pfizer Ltd Therapeutic agents
JPH0248587A (ja) * 1988-08-10 1990-02-19 Yamanouchi Pharmaceut Co Ltd 複素環置換ビスフォスフォン酸誘導体及びその医薬
JPH02286679A (ja) * 1989-04-28 1990-11-26 Grelan Pharmaceut Co Ltd イミダゾピリジン誘導体
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5332744A (en) 1989-05-30 1994-07-26 Merck & Co., Inc. Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
US5298518A (en) 1989-09-29 1994-03-29 Eisai Co., Ltd. Biphenylmethane derivative and pharmacological use
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
EP0434038A1 (en) 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Fused imidazole derivatives, their production and use
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH04235974A (ja) * 1990-06-08 1992-08-25 Roussel Uclaf 新規なイミダゾール誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
WO1992006086A1 (en) 1990-10-01 1992-04-16 Janssen Pharmaceutica N.V. Novel 4-piperidinylcarbonyl derivatives
US5281589A (en) * 1991-06-15 1994-01-25 Cheil Foods & Chemicals, Inc. 3-fused pyridiniummethyl cephalosporins
JPH05201991A (ja) * 1991-07-10 1993-08-10 Dainippon Pharmaceut Co Ltd アミノ酸誘導体
JPH05222058A (ja) 1992-02-17 1993-08-31 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
JPH0641149A (ja) * 1992-05-28 1994-02-15 Toyama Chem Co Ltd 新規なセファロスポリン誘導体およびその塩
JP3269658B2 (ja) * 1992-06-02 2002-03-25 エーザイ株式会社 フェノール誘導体
GB9216287D0 (en) 1992-07-31 1992-09-16 Fujisawa Pharmaceutical Co New cephem compounds
JPH07101958A (ja) 1992-10-16 1995-04-18 Takeda Chem Ind Ltd セフェム化合物、その製造法および抗菌組成物
US5334598A (en) 1993-03-19 1994-08-02 Merck & Co., Inc. Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
DE4309969A1 (de) 1993-03-26 1994-09-29 Bayer Ag Substituierte heteroanellierte Imidazole
JPH07101960A (ja) 1993-10-05 1995-04-18 Takeda Chem Ind Ltd セフェム化合物、その製造法および抗菌組成物
US5486525A (en) 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DE4416433A1 (de) 1994-05-10 1995-11-16 Hoechst Ag Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US5635514A (en) 1994-10-25 1997-06-03 G. D. Searle & Company Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors
US5846990A (en) 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09165371A (ja) 1995-10-09 1997-06-24 Sankyo Co Ltd 複素環化合物を含有する医薬
JPH09110877A (ja) * 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
AUPN955596A0 (en) 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
ZA977103B (en) 1996-08-09 1999-02-08 Eisai Co Ltd Benzopiperidine derivatives
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity

Also Published As

Publication number Publication date
IL143314A0 (en) 2002-04-21
US6518263B1 (en) 2003-02-11
US20030149014A1 (en) 2003-08-07
ZA200103850B (en) 2002-05-13
ES2241374T3 (es) 2005-10-16
EP1134222B1 (en) 2005-04-13
ATE293114T1 (de) 2005-04-15
ID28740A (id) 2001-06-28
KR100692169B1 (ko) 2007-03-12
DE69924751T2 (de) 2006-03-09
RU2223964C2 (ru) 2004-02-20
AU1409000A (en) 2000-06-19
JP3636663B2 (ja) 2005-04-06
CA2350905A1 (en) 2000-06-08
CN100436456C (zh) 2008-11-26
BR9915743A (pt) 2001-08-21
CN1333776A (zh) 2002-01-30
NZ511619A (en) 2002-11-26
CZ20011719A3 (cs) 2001-12-12
WO2000032606A1 (fr) 2000-06-08
PL347897A1 (en) 2002-04-22
EP1134222A1 (en) 2001-09-19
KR20010086058A (ko) 2001-09-07
TW526202B (en) 2003-04-01
TR200101507T2 (tr) 2001-09-21
AU758662B2 (en) 2003-03-27
CA2350905C (en) 2007-10-23
EP1134222A4 (en) 2003-01-29
HUP0200450A3 (en) 2004-04-28
NO20012554L (no) 2001-07-27
HUP0200450A2 (hu) 2002-07-29
DE69924751D1 (de) 2005-05-19
US6800621B2 (en) 2004-10-05

Similar Documents

Publication Publication Date Title
NO20012554L (no) Imidazo[4,5-b]pyridiniummetyl-inneholdende cefemforbindelser med bredt antibakterielt spektrum
HK1087112A1 (en) Tricyclic compounds, their production and use
DK1159279T3 (da) 4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler
ATE203236T1 (de) Neue kondensierte indan-derivate und ihre pharmazeutisch verträglichen salze
ATE172463T1 (de) Pyrrolocarbazol
DE60014143D1 (de) Antimikrobielle 4-oxochinolizine mit 2-pyridongerüsten als teilstruktur
ES2157199T3 (es) Nuevo procedimiento para la produccion de cefalosporinas y nuevos compuestos intermedios para este procedimiento.
DE60125053D1 (de) Cephem verbindungen und diese enthaltende esbl nachweisreagenzien
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
ATE210974T1 (de) Verwendung von derivaten von 2,4-disubstituierten phenolen als 5-lipoxygenaseinhibitoren
PT1338596E (pt) Processos para a preparacao de agentes antibacterianos do tipo carbapenem
DE69424524D1 (de) Neue cephem-derivate
EP1148059A4 (en) THIAZOLPYRIMIDINE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
TH18737EX (th) สารประกอบอินทรีย์

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application